FDA Adverse Event Malfunction Summary report: N

BLOOD GLUCOSE SYSTEM

MDR report key: 5100578 · Received September 24, 2015

Report

Report Number
1052693-2015-01783
Event Type
Malfunction
Date Received
September 24, 2015
Date of Event
August 27, 2015
Report Date
December 31, 2015
Manufacturer
NIPRO DIAGNOSTICS, INC.
Product Code
NBW
PMA / PMN Number
K080641
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). PRODUCT EVALUATION IN PROCESS.

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION COMPLETED AND PRODUCT EVALUATED WITH NO DEFECTS FOUND. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION: USER HAD AN INACCURATE REFERENCE.

Description of Event or Problem · 1

CUSTOMER COMPLAINS OF LOW RESULTS. CUSTOMER STATES THAT HE FEELS PHYSICALLY FINE AND DENIES THE NEED FOR MEDICAL ATTENTION. THE CUSTOMER'S EXPECTED BLOOD RESULTS ARE 90-120MG/DL FASTING. VERIFIED TEST STRIPS EXPIRE 06/16/2018. CONFIRMED CUSTOMER'S TEST STRIPS ARE BEING STORED PROPERLY, AND OPENED VIAL DATE IS 08/24/2015. CUSTOMER PERFORMED A BACK TO BACK BLOOD TEST 158MG/DL AND 158MG/DL BOTH TIMES. REVIEWED METER MEMORY (B)(6). CUSTOMER IS COMPARING HIS TRUERESULT METER TO HIS BROTHERS TRUERESULT METER. HE RAN A BLOOD GLUCOSE TEST ON (B)(6) 2015 @9AM (FASTING) ON HIS TRUERESULT METER HE GOT 55MG/DL AND HIS BROTHERS TRUERESULT METER GAVE HIM 79MG/DL. NO ADVERSE EVENT REPORTED.

Description of Event or Problem · 1

CUSTOMER COMPLAINS OF LOW RESULTS. CUSTOMER STATES THAT HE FEELS PHYSICALLY FINE AND DENIES THE NEED FOR MEDICAL ATTENTION. THE CUSTOMER'S EXPECTED BLOOD RESULTS ARE 90-120MG/DL FASTING. VERIFIED TEST STRIPS EXPIRE 06/16/2018. CONFIRMED CUSTOMER'S TEST STRIPS ARE BEING STORED PROPERLY, AND OPENED VIAL DATE IS (B)(6) 2015. CUSTOMER PERFORMED A BACK TO BACK BLOOD TEST 158MG/DL AND 158MG/DL BOTH TIMES. REVIEWED METER MEMORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
631773 BLOOD GLUCOSE SYSTEM NBW NIPRO DIAGNOSTICS, INC. TRUERESULT REPLACED F

Patients

Seq Age Sex Outcome Treatment
1 0 YR